$AMTX

Aemetis (AMTX) reported Q2 2026 revenue of $62.7M, up 20% YoY, with operating income of $5.8M, reversing a prior-year loss. Growth was driven by ethanol and renewable natural gas segments. Adjusted EBITDA improved to $9.7M from -$5.8M. Management highlighted projects like mechanical vapor recompression and LCFS pathway approvals, but noted risks from uncertain emissions rates and feedstock constraints.

Aemetis (AMTX) Q2 2026 earnings call said consolidated revenue rose 20% year over year, operating income improved by $16.4 million, and adjusted EBITDA increased by $15.5 million versus Q2 2025. The company cited CARB approval of 7 LCFS pathways and pending approvals for 6 digesters, plus ethanol projects including a $32 million annual cash flow MVR system. India biodiesel revenue was $2.5 million, with expected $17 million from new allocations.

Stonegate Capital Partners updated on Aemetis Inc. (NASDAQ: AMTX), saying Q2 2026 showed an operating inflection. Aemetis reported revenue of $62.7M, below consensus $68.6M, but gross profit rose to $13.5M and adjusted EBITDA to $9.7M. Dairy RNG volume rose 38% to 146,900 MMBtu; Stonegate cites 45Z credits and LCFS pathway progress, while noting balance sheet refinancing remains a key constraint.

Simply Wall St reports Aemetis (AMTX) shares rose 5.5% to $1.72 after its Q2 release. Q2 revenue rose to $62.7m from $52.2m. The company swung to operating income of $5.8m from an operating loss, while net loss narrowed to $9.4m. The article cites $1m cash and ongoing liquidity and policy execution risks.

Aemetis Inc. reported Q2 2026 revenue of $62.7 million, up 20% year over year but below the $69.89 million forecast. The company posted an adjusted loss of 13 cents per share versus a 26-cent expected loss, with operating income improving to $5.8 million. It cited Section 45Z credit monetization and expects MVR-related cash flow.

Aemetis reported Q2 2026 revenue of $62.7 million, up $10.5 million (20%) from Q2 2025, including $8.6 million from Section 45Z tax credits. Operating income improved by $16.4 million, net loss narrowed to $9.4 million, and adjusted EBITDA rose to $9.7 million. The company is pursuing refinancing and financing for its Keyes ethanol and Dairy RNG projects, and is considering an IPO for its India unit.

AEMETIS, INC (AMTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 ksmith@pcgadvisory.com Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 investors@aemetis.com Aemetis Reports Second Quarter 2026 Financial Results Revenue Growth o

Aemetis Inc (NASDAQ:AMTX) shares rose 4.3% after its India unit, Universal Biofuels, secured about $17 million in biodiesel supply contracts. Over three months it will deliver more than 18 million liters to India’s three government-owned Oil Marketing Companies, supporting a policy to raise biodiesel blending to 5% by 2030. Additional orders are expected through 2026.

IATA says SAF is 0.6% of jet fuel use versus a 65% net-zero target by 2050, and SAF costs 2 to 5 times more than conventional fuel. A report by IECC at UC Berkeley and Energy Innovation says India could produce SAF via PBtL at up to 40% below global benchmarks, targeting $9B exports by 2030 and $30B by 2040. Aemetis (AMTX) is exploring an IPO for its India unit.

Aemetis, Inc. (NASDAQ: AMTX) said its ethanol and renewable natural gas subsidiaries received about $18 million from selling Section 45Z Clean Fuel Production Tax Credits. It includes $6 million from 2025 ethanol and $12 million from 2026 year-to-date ethanol and RNG. Net cash proceeds were about $14.5 million after costs.